Samir Mitragotri

Samir Mitragotri
Born (1971-05-28) May 28, 1971
Solapur, India
Residence USA
Fields Chemical Engineering, Biomedical Engineering
Institutions University of California, Santa Barbara
Duncan and Suzanne Mellichamp Chair in Systems Biology and Bioengineering
Professor, Chemical Engineering
Director, Center of BioEngineering
Scientific Director, Translational Medicine Research Lab
Affiliated Faculty, Technology Management Program
Alma mater B.S., Institute of Chemical Technology, 1992
M.S. and Ph.D., Massachusetts Institute of Technology, 1996
Doctoral advisor Robert S. Langer, Daniel Blankschtein
Known for Drug Delivery, Biomaterials

Samir Mitragotri (born May 28, 1971) is an Indian American Professor at the University of California, Santa Barbara, an inventor, an entrepreneur, and a researcher in the fields of drug delivery and biomaterials. [1] He is the Duncan and Suzanne Mellichamp Chair in Systems Biology and Bioengineering and the Founding Director of the UC Santa Barbara Center for BioEngineering. [2] [3]

Mitragotri’s key inventions include technologies that make it possible to deliver medicines into the body without using needles. Many modern medicines including vaccines and insulin are delivered by needles, which cause pain, non-compliance, and infections arising from their misuse. Mitragotri has developed technologies to deliver such medicines through skin patches, topical gels, or oral pills. [4] Most vaccines and medicines cannot enter the body by simply rubbing onto the skin or swallowing because the skin and the gut are designed to serve as a barrier for entry. Mitragotri’s technologies are helping overcome this barrier. He has developed ultrasound devices that can be placed on the skin to increase its porosity, thus allowing for the administration of vaccines (sonophoresis), and needle-free jet devices for the direct administration of medicines (liquid jet injector). He has also designed technologies to optimize topical formulations to safely deliver medicines into the body (INSIGHT) and invented a new class of peptides that can facilitate entry of medicines into skin cells. Collectively, Mitragotri’s inventions are making it possible to deliver medicines into the body in a painless way and offer a better alternative to needle injections for the treatment of various diseases, including diabetes, infectious diseases, and various dermatological conditions.

Research in the Mitragotri laboratory is also focused on the engineering of synthetic red blood cells and platelets. These are synthetic particles made from polymers and proteins that mimic key structural properties and certain functional properties of natural blood cells for potential applications in the detection and treatment of cardiovascular diseases.[5]

Mitragotri has published over 200 publications in the area of drug delivery and biomaterials, has given over 250 invited presentations worldwide, and is an inventor on over 100 issued patents. His publications are cited with an h-index of 75.[6] Mitragotri is a co-founder of several companies that are developing products based on his inventions for detection and treatment of various human diseases. He received his Ph.D. in Chemical Engineering at MIT and B.S. in Chemical Engineering from the Institute of Chemical Technology. Mitragotri serves on the editorial boards of several journals and currently serves as an Associate Editor of Journal of Controlled Release.

Awards and Honors

Mitragotri's national and international awards include:

Journal Associations

Biotech Companies

Samir Mitragotri has co-founded several companies:

References

  1. ↑ "Mitragotri Laboratory, UCSB Chemical Engineering". Drug Delivery UCSB Engineering. The Regents of the University of California. Retrieved 14 October 2014.
  2. ↑ "Endowed Chairs". UCSB Institutional Advancement, Office of Development. The Regents of the University of California. Retrieved 14 October 2014.
  3. ↑ "People". UCSB Center for BioEngineering. The Regents of the University of California. Retrieved 14 October 2014.
  4. ↑ Mitragotri, Samir (Winter 2008). "Recent Development in Needle-Free Drug Delivery". The Bridge: Linking Engineering and Society 38 (4): 5–12.
  5. ↑ Gravitz, Lauren. "Artificial Red Blood Cells for Drug Delivery". MIT Technology Review. MIT Technology Review. Retrieved 15 December 2009.
  6. ↑ "Samir Mitragotri". Google Scholar. Google Scholar. Retrieved 14 October 2014.
  7. ↑ "BMES members elected to 2015 National Academy of Engineers class". BMES. Biomedical Engineering Society. Retrieved 4 January 2016.
  8. ↑ Baumer, Katie. "AAPS Announces 2015 Fellows". AAPS. American Association of Pharmaceutical Scientists (AAPS). Retrieved 4 January 2016.
  9. ↑ "College of Fellows". Controlled Release Society. Controlled Release Society. Retrieved 1 July 2015.
  10. ↑ "Professional Progress in Chemical Engineering". AIChE: The Global Home of Chemical Engineers. American Institute of Chemical Engineers. Retrieved 1 July 2015.
  11. ↑ Atkins, Randy. "National Academy of Engineering Elects 67 Members and 12 Foreign Members". National Academy of Engineering. Retrieved 7 February 2015.
  12. ↑ "Current NAI Fellows". National Academy of Inventors. The National Academy of Inventors. Retrieved 14 October 2014.
  13. ↑ Fernandez, Sonia. "Two UCSB Engineering Professors Named to National Academy of Inventors". The UC Santa Barbara Current: Science & Technology. The Regents of the University of California. Retrieved 17 December 2013.
  14. ↑ "AAAS Members Elected as Fellows". AAAS. American Association for the Advancement of Science. Retrieved 30 November 2012.
  15. ↑ "Eight Distinguished UCSB Faculty Members Named AAAS Fellows". UCSB Institutional Advancement: Public Affairs & Communications. The Regents of the University of California. Retrieved 29 November 2012.
  16. ↑ "Fellow Directory". AIMBE. American Institute for Medical and Biological Engineering. Retrieved 30 September 2014.
  17. ↑ "CRS Young Investigator Award Recipients". CRS: Controlled Release Society. Controlled Release Society. Retrieved 14 October 2014.
  18. ↑ "Allan P. Colburn Award for Excellence in Publications by a Young Member of the Institute". AIChE: The Global Home of Chemical Engineers. American Institute of Chemical Engineers. Retrieved 14 October 2014.
  19. ↑ "Samir Mitragotri, 28". MIT Technology Review. MIT Technology Review. Retrieved 2013.
  20. ↑ "Bioengineering & Translational Medicine". AIChE. American Institute of Chemical Engineers. Retrieved 4 January 2016.
  21. ↑ "Editorial Board, Journal of Controlled Release". Elsevier. Elsevier B.V. Retrieved 14 October 2014.
  22. ↑ "European Journal of Pharmaceutical Sciences Editorial Board". Elsevier. Elsevier B.V. Retrieved 14 October 2014.
  23. ↑ Echo Therapeutics: Needle-free monitoring and drug delivery. Echo Therapeutics http://www.echotx.com/. Retrieved 14 October 2014. Missing or empty |title= (help)
  24. ↑ "Scientific Advisors". Seventh Sense Biosystems. Seventh Sense Biosystems, Inc. Retrieved 14 October 2014.
  25. ↑ "Team". entrega. Entrega Bio. Retrieved 14 October 2014.
  26. ↑ "CTX Acquires Promising Proprietary Drug Delivery Assets". Business Wire. Business Wire. Retrieved 4 January 2016.

External Links

This article is issued from Wikipedia - version of the Monday, January 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.